Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 236 (1) , 64-71
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- CrELISA: a fast and robust enzyme-linked immunosorbent assay bypassing the need for purification of recombinant proteinJournal of Immunological Methods, 2004
- Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissuesInternational Journal of Cancer, 2001
- Antibody Responses to Melanoma/Melanocyte Autoantigens in Melanoma PatientsJournal of Investigative Dermatology, 1998
- Cancer Tumor antigensCurrent Opinion in Immunology, 1997
- Identification of Genes Coding for Tumor Antigens Recognized by Cytolytic T LymphocytesMethods, 1997
- Molecular Definition of a Novel Human Galectin Which Is Immunogenic in Patients with Hodgkin's DiseaseJournal of Biological Chemistry, 1997
- Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3International Journal of Cancer, 1995
- Serum p53 antibodies as early markers of lung cancerNature Medicine, 1995
- Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancersInternational Journal of Cancer, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991